NCT/Study#

KARYOPHARM-RWE

Treatment patterns and adverse event management in patients treated with selinexor in combination with other approved agents for relapsed/refractory multiple myeloma: Real-world evidence based on electronic medical record data

Treatment patterns and adverse event management in patients treated with selinexor in combination with other approved agents for relapsed/refractory multiple myeloma: Real-world evidence based on electronic medical record data

DISEASE GROUP:
Multiple Myeloma
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: